The trading price of Health In Tech Inc (NASDAQ:HIT) closed lower on Monday, April 14, and closing at $0.69, -1.87% lower than its previous close.
Traders who pay close attention to intraday price movement should know that it fluctuated between $0.65 and $0.78. The company’s P/E ratio in the trailing 12-month period was 55.40. In examining the 52-week price action we see that the stock hit a 52-week high of $7.59 and a 52-week low of $0.51. Over the past month, the stock has lost -15.84% in value.
Health In Tech Inc, whose market valuation is $37.51 million at the time of this writing, is expected to release its quarterly earnings report in May. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by 0.02 per share this quarter, however they have predicted annual earnings per share of 0.06 for current year and 0 for next year.
Analysts have forecast the company to bring in revenue of 6M for the current quarter, with the likely lows of 6M and highs of 6M. From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue is 22.99M.
A quick review shows that HIT’s price is currently 2.67% off the SMA20 and -81.43% off the SMA50. The RSI metric on the 14-day chart is currently showing 24.39, and weekly volatility stands at 15.77%. When measured over the past 30 days, the indicator reaches 17.67%. Health In Tech Inc (NASDAQ:HIT)’s beta value is currently sitting at 0, while the Average True Range indicator is currently displaying 0.25.
To see how Health In Tech Inc stock has been performing in comparison to its peers in the industry, here are the numbers: HIT stock’s performance was -1.87% in the latest trading. Health In Tech Inc has a P/E ratio of 55.40.
An evaluation of the daily trading volume of Health In Tech Inc (NASDAQ:HIT) indicates that the 3-month average is 1.94 million. However, this figure has increased over the past 10 days to an average of 0.66.
Currently, records show that 42.91 million of the company’s shares remain outstanding. The insiders hold 85.60% of outstanding shares, whereas institutions hold 0.01%. The stats also highlight that short interest as of 2025-03-31, stood at 0.43 million shares, resulting in a short ratio of 0.13 at that time. From this, we can conclude that short interest is 352.00 of the company’s total outstanding shares. It is noteworthy that short shares in March were up slightly from the previous month’s figure, which was 0.12 million. However, since the stock’s price has seen -87.17% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
